Synthesis and biological evaluation of amide-linked A-norpaclitaxels

Tetrahedron

Volumn 53, Issue 16, 1997, Pages 5699-5710

  Chordia, Mahendra D ^a   Kingston, David G I ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; TAXANE DERIVATIVE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SYNTHESIS; IN VITRO STUDY; LEUKEMIA P 388; MICROTUBULE ASSEMBLY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REACTION ANALYSIS; STEREOCHEMISTRY; THIN LAYER CHROMATOGRAPHY;

ANIMALIA; STAPHYLOCOCCUS PHAGE 3A;

EID: 0030900922     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4020(97)00281-0     Document Type: Article

References (31)

1. For recent reviews see: a) McGuire, W. P.; Rowinsky, E. K., Eds. Paclitaxel in Cancer Treatment; M. Dekker, Inc: New York, 1995; pp 1-349.
2. b) Georg, G. I.; Chen, T. T.; Ojima, I.; Vyas, D. M., Eds. Taxane Anticancer Agents. Basic Science and Current Status. ACS Symposium Series 583, American Chemical Society: Washington DC, 1995; pp 1-353.
3. c) Suffness, M., Ed. Taxol: Science and Applications: CRC Press: Boca Raton, Florida, 1995; pp 1-426.
4. d) Farina, V., Ed. The Chemistry and Pharmacology of Taxol and its Derivatives. Elsevier: Amsterdam, 1995; pp 1-336..
5. e) K. C. Nicolaou, W. M. Dai and R. K. Guy, Angew. Chem. Int. Ed. Engl. 1994, 3315-44.
6. f) D. G. I. Kingston, Trends Biotech. 1994, 12, 222-227.
7. a) Georg, G. I.; Boge, T. C.; Cheruvallath Z. S.; Clowers, J. S., Harriman, G. C. B.; Hepperle, M.; Park, H. The Medicinal Chemistry of Taxol. In Taxol: Science and applications; Suffness M. Ed.;. CRC Press: Boca Raton. 1995; pp 317-375.
8. b) Kant, J. The Chemistry of the Taxol Side Chain: Synthesis Modifications and Conformational Studies. In The Chemistry and Pharmacology of Taxol and its Derivatives; Farina, V., Ed.; Elsevier Science B. V.: Amsterdam. 1995; pp 255-300.
9. c) Ojima, I.; Park, Y. H.; Fenoglio, I.; Duclos, O.; Sun, C.-M.; Kuduk, S. D.; Zucco, M.; Appendino, G.; Pera, P.; Veith, J. M.; Bernacki, R. J.; Bissery, M.-C.; Combeau, C.; Vrignaud, P.; Riou, J. G.; Lavelle, F. Syntheses and Structure-Activity Relationships of New Taxoids. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, I.; Vyas, D. M., Ed.; American Chemical Society: Washington, DC, 1995; Vol. ACS Symposium Series 583; pp 262-275.
10. d) Ojima, I.; Slater, J. C.; Michaud, E.; Kuduk, S. C.; Bounaud, P.-Y.; Vrignaud, P.; Bissery, M.-C.; Veith, J. M.; Pera, P.; Bernacki, R. J. J. Med. Chem. 1996, 39, 3889-3896.
11. See, e.g.a) D. G. I. Kingston in Taxane Anticancer Agents. Basic Science and Current Status. ACS Symposium Series 583, American Chemical Society, Washington, DC, 1995, pp 203-216.
12. b) Chen S. H.; Farina, V. Paclitaxel (Taxol) Chemistry and Structure-Activity Relationships. In The Chemistry and Pharmacology of Taxol and its Derivatives; Farina, V., Ed.; Elsevier Science B. V.: Amsterdam. 1995; pp 165-253.
13. a) Chaudhary, A. G.; Gharpure, M. M.; Rimoldi, J. M.; Chordia, M. D.; Gunatilaka, A. A. L.; Kingston, D. G. I.; Grover, S.; Lin, L. M.; Hamel, E. J. Am. Chem. Soc. 1994, 116, 4097-4098.
14. b) Nicolaou, K. C.; Renaud, J.; Nantermet, P. G.; Couladouros, E. A.; Guy, R. K.; Wrasidlo, W. J. Am. Chem. Soc. 1995, 117, 2409-2410.
15. c) Georg, G. I.; Ali, S. M.; Boge, T. C.; Datta, A.; Falborg, L.; Park, H.; Mejillano, M.; Himes, R. H. Bioorg. Med. Chem. Lett. 1995, 5, 259-264.
16. Samaranayake, G.; Magri, N. F.; Jitrangsri, C.; Kingston, D. G. I. J. Org. Chem. 1991, 56, 5114-5119.
17. Chordia, M. D.; Kingston, D. G. I.; Hamel, E.; Lin, C. M.; Long, B. H.; Fairchild. C.; Johnston, K. A.; Rose, W. C. Bioorg. Med. Chem., in press (1997).
18. Hamel, E. Personal communication.
19. Chen, S.-H.; Farina, V.; Vyas, D. M.; Doyle, T. W.; Long, B. H.; Fairchild. C. J. Org. Chem., 1996, 61, 2065-2070.
20. Denis, J.-N.; Greene, A. E.; Guenard, D.; Gueritte-Voegelein, F.; Mangatal, L.; Potier, P. J. Am. Chem. Soc. 1988, 110, 5917-5919.
21. This compound has recently been prepared independently by another route (reference 8).
22. Zaloom, J.; Calandra, M; Roberts, D. C. J. Org. Chem. 1985, 50, 2601-2603.
23. Commercon, A.; Bezard, D.; Bernard, F.; Bourzat, J. D. Tetrahedron Lett. 1992, 33, 5185-5188.
24. Samaranayake, G.; Neidigh, K. A.; Kingston, D. G. I. J. Nat. Prod. 1993, 56, 884-898.
25. Ghosh, S. K.; Singh, U.; Mamdapur, V. R. Tetrahedron Lett., 1992, 33, 805-808.
26. Georg, G. I.; Boge, T. C.; Cheruvallath, Z. S.; Harriman, G. C. B.; Hepperle, M.; Park, H. Bioorg. Med. Chem. Lett. 1994, 4, 335-338.
27. a) Neidigh, K. A.; Gharpure, M. M.; Rimoldi, J. M.; Kingston, D. G. I.; Jiang, Y. Q.; Hamel, E. Tetrahedron Lett. 1994, 35, 6839-6842;
28. b) Grover, S.; Rimoldi, J. M.; Molinero, A. A.; Chaudhary, A. G.; Kingston, D. G. I.; Hamel, E. Biochemistry 1995, 34, 3927-3934.
29. Chordia, M. D.; Kingston, D. G. I. J. Org. Chem. 1996, 61, 799-801.
30. Neidigh, K. A.Chemical Studies of the C-4 Position of Baccatin III and Taxol, Virginia Polytechnic Institute and State University 1996.
31. Cytotoxicities were determined by Dr. W. Lichter, University of Miami School of Medicine, using standard NCI protocols.